# Ultra-hypofractionated for Whole Breast Irradiation (WBI) Compared to Partial Breast Irradiation (PBI)

> **NCT05914831** · PHASE2 · RECRUITING · sponsor: **Oncology Institute of Vojvodina** · enrollment: 100 (estimated)

## Conditions studied

- Breast Cancer Female

## Interventions

- **RADIATION:** Ultra-fractionated WBI
- **RADIATION:** Ultra-fractionated PBI

## Key facts

- **NCT ID:** NCT05914831
- **Lead sponsor:** Oncology Institute of Vojvodina
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-06-01
- **Primary completion:** 2026-05-31
- **Final completion:** 2033-05-31
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2023-07-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05914831

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05914831, "Ultra-hypofractionated for Whole Breast Irradiation (WBI) Compared to Partial Breast Irradiation (PBI)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05914831. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
